The long-term safety and efficacy of opioids: a survey of 84 selected patients with intractable chronic noncancer pain.
BACKGROUND
The use of opioids for chronic noncancer pain (CNCP) remains controversial. Despite a number of randomized controlled trials showing efficacy and safety in the short term, long-term data are limited.


OBJECTIVE
To survey a selected cohort of patients with intractable CNCP with regard to long-term efficacy and safety of opioids.


METHODS
The present study reports long-term results from a survey of 84 patients with CNCP. The majority of patients had neuropathic pain, were treated with opioids and were followed every three months for a median of 8.4 years. Outcomes examined were pain severity, adverse effects, pain relief, satisfaction, mood, problematic opioid use, tolerance, physical dependency, functional status, health-related quality of life, immune status, sexual function, morbidity and mortality. Measures included a numerical rating scale, the Hospital Anxiety and Depression Scale, Brief Pain Inventory interference scale, Pain Disability Index and Short-Form Health Survey 12, version 2.


CONCLUSIONS
Both long- and short-acting opioids were reported to be effective, with few significant long-term adverse effects in many subjects in the present selected cohort. The majority of patients reported at least 50% or greater pain relief and a moderate improvement in disability. Functional status and health-related quality of life scores were not severely affected. Problematic opioid use, tolerance and serious adverse effects, including constipation, were not major issues. The authors emphasize that the results obtained in the present selected group may not be generalizable to all CNCP patients in whom opioids are being initiated.
Watson
C Peter N
CP
Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. peter.watson@utoronto.ca
Watt-Watson
Judy
J
Chipman
Mary
M
D000368:Aged; D000369:Aged, 80 and over; D000701:Analgesics, Opioid / Q000627:therapeutic use*; D002908:Chronic Disease; D004185:Disability Evaluation; D004305:Dose-Response Relationship, Drug; D005260:Female; D006306:Health Surveys; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D019370:Observation; D010146:Pain / Q000188:drug therapy* / Q000523:psychology; D010147:Pain Measurement; D011788:Quality of Life; D012189:Retrospective Studies; D016896:Treatment Outcome
D000701:Analgesics, Opioid
Med Care. 1996 Mar;34(3):220-33
8628042
N Engl J Med. 2005 Mar 31;352(13):1324-34
15800228
Neurology. 2003 Mar 25;60(6):927-34
12654955
Pain. 2005 Jan;113(1-2):9-19
15621359
Pain. 1986 May;25(2):171-186
2873550
Neurology. 1998 Jun;50(6):1837-41
9633737
Pain. 2007 Jun;129(3):235-255
17482363
J Pain Symptom Manage. 1992 Feb;7(2):69-77
1573287
Eur J Pain. 2006 Jul;10(5):423-33
16054407
Pain. 1990 Feb;40(2):171-182
2308763
Pain. 1999 Oct;83(1):85-90
10506675
Cancer. 2004 Feb 15;100(4):851-8
14770444
Neurology. 1998 Jun;50(6):1842-6
9633738
J Pain Symptom Manage. 1993 Jul;8(5):257-64
7963767
NIDA Res Monogr. 1988;81:174-80
3136358
Arch Phys Med Rehabil. 1994 Oct;75(10):1082-6
7944912
Br J Pharmacol. 1997 Jun;121(4):834-40
9208156
Pain. 1997 Dec;73(3):393-400
9469530
Pain. 2002 Dec;100(3):213-217
12467992
Pain. 2003 Jul;104(1-2):323-31
12855342
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
6880820
J Pain Symptom Manage. 2000 Feb;19(2):100-8
10699537
Am J Ther. 2004 Sep-Oct;11(5):354-65
15356431
Pain. 2003 Sep;105(1-2):71-8
14499422
J Pain Symptom Manage. 1996 May;11(5):274-86
8636626
Pain. 1983 Oct;17(2):197-210
6646795
Pain Res Manag. 2004 Spring;9(1):19-24
15007399
N Engl J Med. 2003 Mar 27;348(13):1223-32
12660386
Neurology. 2002 Oct 8;59(7):1015-21
12370455
Pain. 2006 Nov;125(1-2):172-9
16842922